These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36436672)

  • 21. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
    Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
    J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
    Zeuschner P; Vollmer SG; Linxweiler J; Wagenpfeil G; Wagenpfeil S; Saar M; Siemer S; Stöckle M; Heinzelbecker J
    Surg Oncol; 2021 Sep; 38():101607. PubMed ID: 34022505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy.
    Aumatell J; Huguet J; Subiela JD; Gaya JM; Faba ÓR; Territo A; Palou J; Breda A
    Urol Oncol; 2021 Oct; 39(10):732.e1-732.e8. PubMed ID: 33863619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy.
    Khanna A; Zganjar A; Lyon T; Shah P; Tollefson MK; Karnes RJ; Tarrell R; Thapa P; Thompson RH; Frank I; Boorjian SA
    J Urol; 2021 Oct; 206(4):970-977. PubMed ID: 34032500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
    Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
    J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Fang D; Seisen T; Yang K; Liu P; Fan X; Singla N; Xiong G; Zhang L; Li X; Zhou L
    Eur J Surg Oncol; 2016 Nov; 42(11):1625-1635. PubMed ID: 27612412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
    Tollefson MK; Boorjian SA; Farmer SA; Frank I
    World J Urol; 2012 Dec; 30(6):795-9. PubMed ID: 22447397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
    Favaretto RL; Shariat SF; Chade DC; Godoy G; Adamy A; Kaag M; Bochner BH; Coleman J; Dalbagni G
    Eur Urol; 2010 Oct; 58(4):574-80. PubMed ID: 20637540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
    Rehme C; Fritsch B; Thomas L; Istin S; Burchert C; Hummel B; Baleanu-Curaj B; Reis H; Szarvas T; Ruebben H; Hadaschik B; Niedworok C
    Int Urol Nephrol; 2022 Jan; 54(1):71-79. PubMed ID: 34817753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of renal function for upper tract urothelial carcinoma who underwent radical nephroureterectomy: Sex differences.
    Chien TM; Li CC; Lu YM; Chang HW; Chou YH; Wu WJ
    J Formos Med Assoc; 2022 Nov; 121(11):2182-2190. PubMed ID: 35370029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan.
    Chen IA; Chang CH; Huang CP; Wu WJ; Li CC; Chen CH; Huang CY; Lo CW; Yu CC; Tsai CY; Wu WC; Tseng JS; Lin WR; Jiang YH; Lee YK; Jou YC; Cheong IS; Hsueh TY; Chiu AW; Chen YT; Chen JS; Chiang BJ; Tsai YC; Lin WY; Wu CC; Lin JT; Yu CC
    Front Oncol; 2021; 11():766576. PubMed ID: 35096575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
    Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Tabata M; Kaneko T; Taguchi S; Naito A; Hikatsu M; Sato Y; Murata T; Matsumoto A; Miyazaki H; Suzuki M; Enomoto Y; Nishimatsu H; Kondo Y; Takeuchi T; Tanaka Y; Kume H
    Jpn J Clin Oncol; 2021 Oct; 51(10):1577-1586. PubMed ID: 34047345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
    Soria F; Pisano F; Gontero P; Palou J; Joniau S; Serretta V; Larré S; Di Stasi S; van Rhijn B; Witjes JA; Grotenhuis A; Colombo R; Briganti A; Babjuk M; Soukup V; Malmstrom PU; Irani J; Malats N; Baniel J; Mano R; Cai T; Cha E; Ardelt P; Varkarakis J; Bartoletti R; Dalbagni G; Shariat SF; Xylinas E; Karnes RJ; Sylvester R
    World J Urol; 2018 Nov; 36(11):1775-1781. PubMed ID: 30171454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.